Actively Recruiting

Age: 18Years +
FEMALE
NCT07539038

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Led by Centro di Riferimento Oncologico - Aviano · Updated on 2026-04-20

44

Participants Needed

1

Research Sites

143 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life. This is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).

CONDITIONS

Official Title

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with early stage (I-IIIa) hormone receptor-positive breast cancer receiving adjuvant endocrine therapy
  • Female patients 18 years of age or older
  • Written informed consent must be obtained before any study-related assessment is performed
  • Participation in the Medicina and Sport physical activity program organized by Andos Pordenone
Not Eligible

You will not qualify if you...

  • Patients with early hormone receptor-negative breast cancer
  • Patients with early hormone receptor-positive breast cancer receiving chemotherapy
  • Patients with advanced or metastatic breast cancer
  • Patients receiving active treatment for secondary primary tumors (excluding basal cell carcinoma or in situ neoplasias)
  • Patients with a history of vertebral and/or femoral fractures
  • Patients with cardiovascular diseases not optimally controlled by medical therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centro di Riferimento Oncologico di Aviano

Aviano, Pordenone, Italy, 33081

Actively Recruiting

Loading map...

Research Team

M

Mattia Garutti

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here